Pharma tariff row: Common ailment, uncommon prescription - Fortune India

Pharma tariff row: Common ailment, uncommon prescription – Fortune India

August 8, 2026

Pharma tariff row: Common ailment, uncommon prescription Fortune IndiaUS generics tariffs more negotiation tactic than real threat: Biocon’s Kiran Mazumdar-Shaw livemint.comSandoz in Talks With U.S. Government About Potential Investment, CEO Says WSJPower, politics and pharma Express PharmaTariff Update: New Section 232 Tariffs Take Effect for Certain Patented Pharmaceutical Imports Marken.